EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

ReFerm® a Fermented Oat Gruel Composition, Improves Colonic Barrier Function and Modulates Tricellulin Expression in Patients With Irritable Bowel Syndrome

Vittorio Abruzzese iD, Olga Biskou iD, Martin E Winberg iD, Hans Israelsen iD, Olga Bednarska iD, Susanna Walter iD, Åsa V Keita iD

Neurogastroenterology & Motility · 2026-06 · 38 (6)

DOI: 10.1111/nmo.70381 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 23.06.2026. Verfasst von Vittorio Abruzzese und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Intestinal Barrier Function, Colon, MARVEL Domain Containing 2 Protein. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dr Per Håkanssons stiftelse, Medical Infection and Inflammation Center-MIIC, Grants, Region Östergötland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intestinal barrier dysfunction has been implicated in the pathophysiology of irritable bowel syndrome (IBS), contributing to increased permeability, low‐grade inflammation, and symptom generation. Microbial compositions are known to improve epithelial barrier function, although the underlying molecular mechanisms remain elusive. The aim was to investigate the effects of the fermented oat gruel preparation ReFerm® on colonic barrier function and tight junction protein expressions in patients with IBS.

Methods

Colonic biopsies from patients with IBS were mounted in Ussing chambers to assess the direct effects of ReFerm® on epithelial permeability. In parallel, biopsies from patients treated with ReFerm® or placebo by enema were analyzed for the expression of multiple tight junction proteins using Western blotting and confocal microscopy. In vitro effects were further evaluated in Caco‐2 cells. Key Results ReFerm® reduced both paracellular and transcellular permeability when added directly to biopsies mounted in Ussing chambers, compared with unstimulated biopsies. This effect was accompanied by increased expression of the tight junction protein tricellulin at tricellular junctions. In vitro experiments in Caco‐2 cells supported these findings, demonstrating direct effects of ReFerm® on epithelial barrier properties. Conclusions and Interferences ReFerm® strengthens colonic barrier integrity in the gut mucosa of patients with IBS, potentially through modulation of the tight junction protein tricellulin. These findings provide mechanistic insight into the barrier‐protective effects of fermented oat interventions such as ReFerm® and support the potential therapeutic role in IBS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeIntestinal Barrier FunctionColonMARVEL Domain Containing 2 ProteinAvenaIntestinal MucosaFermented FoodsHumansCaco-2 CellsFemaleMaleMiddle AgedAdultTight JunctionsPermeability

Stichwörter der Autor:innen

fermented oatsfunctional gastrointestinal disordergut permeabilityintestinal barrierirritable bowel syndrometight junctions

Substanzen

MARVEL Domain Containing 2 ProteinMARVELD2 protein, human

Autor:innen und Institutionen

  • Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Nordic Rebalance A/S, Hillerød, Denmark.
  • Department of Gastroenterology, Linköping University Hospital, Linköping, Sweden.
  • Department of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden.

ORCID-Profile: Vittorio Abruzzese, Olga Biskou, Martin E Winberg, Hans Israelsen, Olga Bednarska, Susanna Walter, Åsa V Keita

Förderung

  • Dr Per Håkanssons stiftelse
  • Medical Infection and Inflammation Center-MIIC
  • Grants, Region Östergötland
  • Bengt Ihres Foundation
  • Ruth och Richard Julins Stiftelse
  • Stiftelsen Apotekare Hedbergs Fond för Medicinsk Forskning

Zitieren

APA

Abruzzese, V., Biskou, O., Winberg, M. E., Israelsen, H., Bednarska, O., Walter, S., & Keita, Å. V. (2026). ReFerm® a Fermented Oat Gruel Composition, Improves Colonic Barrier Function and Modulates Tricellulin Expression in Patients With Irritable Bowel Syndrome. Neurogastroenterology & Motility, 38(6). https://doi.org/10.1111/nmo.70381

Vancouver

Abruzzese V, Biskou O, Winberg ME, Israelsen H, Bednarska O, Walter S, et al. ReFerm® a Fermented Oat Gruel Composition, Improves Colonic Barrier Function and Modulates Tricellulin Expression in Patients With Irritable Bowel Syndrome. Neurogastroenterology & Motility. 2026;38(6). doi:10.1111/nmo.70381

BibTeX
@article{Abruzzese2026,
  author = {Abruzzese, Vittorio and Biskou, Olga and Winberg, Martin E and Israelsen, Hans and Bednarska, Olga and Walter, Susanna and Keita, Åsa V},
  title = {ReFerm® a Fermented Oat Gruel Composition, Improves Colonic Barrier Function and Modulates Tricellulin Expression in Patients With Irritable Bowel Syndrome},
  journal = {Neurogastroenterology & Motility},
  year = {2026},
  volume = {38},
  number = {6},
  doi = {10.1111/nmo.70381}
}
Kostenlos starten →